Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New exercise program aims to boost recovery after second hip replacement

NCT ID NCT05657054

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 16-week hip strengthening exercise program, done mostly at home with some physiotherapist guidance, can improve physical function and reduce pain in people undergoing a second hip replacement. About 84 participants will be randomly assigned to either the exercise program or standard community rehabilitation. The main goal is to see if the exercise group performs better on a sit-to-stand test after 16 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
exercise intervention targeting hip strengthening
What this could lead to
If it works, this could point toward a better rehabilitation program for people undergoing revision hip replacement, improving their physical function and reducing pain.
What could go wrong
This is a small, early-stage trial with only 84 participants, so results may not apply to everyone. The exercise program may be no better than standard rehab, and some patients may find it difficult to complete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2022

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing first revision THR * Age ≥ 18 years * Motivated to participate in an exercise program for 16 weeks * Provided informed consent to participate * Patients who has the cup and/or stem replaced or a combination of liner and caput replaced * Patients who can be baseline tested (chair stand test, stair climb test, 40m walking test) Exclusion Criteria: * Dependency of wheelchair * Preplanned other lower limb surgery within 12 months * Body Mass Index (BMI) score \> 40 * Currently undergoing cancer treatment, e.g. chemo-, immuno-, or radiotherapy. * Comorbidities that prevent exercise * Inadequacy in written and spoken Danish * Mentally unable to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Revision total hip arthroplasty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aarhus University

    Aarhus, 8000, Denmark

  • Aarhus University Hospital

    Aarhus N, 8200, Denmark

  • Bispebjerg Hospital

    Copenhagen, 2400, Denmark

  • Gødstrup Hospital

    Herning, 7400, Denmark

  • Odense University Hospital

    Odense, 5000, Denmark

  • Regional Hospital Silkeborg

    Silkeborg, 9640, Denmark

  • Regional Hospital Viborg

    Viborg, 8800, Denmark

  • University Hospital, Gentofte, Copenhagen

    Hellerup, 2900, Denmark

  • Vejle Hospital

    Vejle, 7100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.